BFC Planning’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.91K Hold
1,324
– – ﹤0.01% 2894
2026
Q2
$3.39K Buy
+1,324
New +$3.18K ﹤0.01% 2825

Other funds holding LPCN

BFC Planning's LPCN Position: Q3 2026 in Review

BFC Planning held its Lipocine (LPCN) position steady in Q3 2026 at 1,324 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

BFC Planning first reported a position in LPCN in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.39K in Q2 2026. 24 funds tracked by Wall St. Rank hold LPCN as of Q3 2026.

  • BFC Planning held 1,324 shares of Lipocine worth $2.91K as of Q3 2026.
  • BFC Planning left its Lipocine share count unchanged in Q3 2026.
  • Lipocine made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2894 holding.
  • BFC Planning first reported a position in Lipocine in Q2 2026 and has held it in 2 quarters since.
  • BFC Planning's Lipocine position peaked at $3.39K in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.